We are live on ! Find out more
CH

CVI Holdings Portfolio holdings

AUM $116M
1-Year Est. Return 5.68%
This Fund
S&P 500
This Quarter Est. Return
-0.91%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
AUM
$60.5M
AUM Growth
-$19.9M
Cap. Flow
-$41.8M
Cap. Flow %
-69.1%
Top 10 Hldgs %
84.49%
Holding
67
New
15
Increased
Reduced
12
Closed
20

Sector Composition

Rank Sector Weight
1 Healthcare 33.08%
2 Consumer Discretionary 10.33%
3 Communication Services 6.4%
4 Materials 2.51%
5 Technology 1.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOO
1
Bombardier Recreational Products
DOO
$4.58B
$6.25M 10.33%
+133,226
New +$6.19M
GTHX
2
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$4.41M 7.29%
+84,249
New +$4.59M
ADXS
3
DELISTED
Advaxis Inc
ADXS
$3.23M 5.35%
+229,290
New +$4.47M
NTBL
4
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$2.83M 4.68%
49,717
-4,480
-8% -$284K
ALDX icon
5
Aldeyra Therapeutics
ALDX
$96.5M
$2.76M 4.57%
+200,000
New +$1.62M
BBGI icon
6
Beasley Broadcasting Group
BBGI
$36.4M
$2.52M 4.17%
+18,259
New +$2.89M
MRKR icon
7
Marker Therapeutics
MRKR
$18.7M
$2.26M 3.74%
25,000
EMWP
8
DELISTED
Eros Media World PLC
EMWP
$1.35M 2.23%
5,600
-42,412
-88% -$10.9M
NOVN
9
DELISTED
Novan, Inc. Common Stock
NOVN
$939K 1.55%
33,666
-6,847
-17% -$190K
FURY
10
Fury Gold Mines
FURY
$105M
$930K 1.54%
586,404
-74,171
-11% -$117K
WHWK
11
Whitehawk Therapeutics
WHWK
$190M
$896K 1.48%
19,342
-10,703
-36% -$601K
ALAR
12
Alarum Technologies
ALAR
$12.3M
$895K 1.48%
+526
New +$1.17M
ARGX icon
13
argenx
ARGX
$54.6B
$874K 1.45%
+11,527
New +$1.02M
URG
14
Ur-Energy
URG
$497M
$586K 0.97%
+732,548
New +$556K
ATXS
15
DELISTED
Astria Therapeutics
ATXS
$584K 0.97%
12,172
-32,507
-73% -$1.46M
BNBX
16
DELISTED
BNB PLUS CORP
BNBX
-1
Closed -$781K
ALT icon
17
Altimmune
ALT
$580M
$408K 0.67%
+92,768
New +$1.01M
OPNT
18
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
$245K 0.41%
+13,715
New +$238K
RDHL
19
Redhill Biopharma
RDHL
$3.84M
$198K 0.33%
+22
New +$179K
IRIX icon
20
IRIDEX
IRIX
$14.5M
$164K 0.27%
+25,799
New +$192K
NVIV
21
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$146K 0.24%
96
-113
-54% -$167K
CHEKZ
22
DELISTED
Check-Cap Ltd. Series C Warrant
CHEKZ
$102K 0.17%
136,364
SHIPW
23
DELISTED
Seanergy Maritime Holdings Corp Class A Warrants
SHIPW
$100K 0.17%
1,180,400
BVXVW
24
DELISTED
BiondVax Pharmaceuticals Ltd.
BVXVW
$85K 0.14%
72,800
RXIIW
25
DELISTED
RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021
RXIIW
$77K 0.13%
221,015
-41
-0% -$19

Similar funds

CVI Holdings's Q3 2018 Portfolio in Review

As of Q3 2018, CVI Holdings held 67 positions worth $60.5M, down 25% from $80.3M the previous quarter. Its ten largest holdings account for 84% of the portfolio.

CVI Holdings withdrew a net $41.8M in Q3 2018, closing 20 positions and reducing 12 holdings. Its most notable exit was Novavax, an estimated $4.44M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, CVI Holdings opened a new position in Bombardier Recreational Products worth $6.25M.

  • CVI Holdings's largest Q3 2018 buy was Bombardier Recreational Products: 133,226 shares worth $6.25M.
  • CVI Holdings's biggest Q3 2018 reduction was Eros Media World PLC, cutting an estimated $10.9M.
  • CVI Holdings fully exited Novavax in Q3 2018, selling an estimated $4.44M.
  • CVI Holdings's ten largest holdings make up 84% of its $60.5M portfolio in Q3 2018.
  • CVI Holdings opened 15 new positions and closed 20 in Q3 2018.
  • CVI Holdings's portfolio value fell 25% quarter-over-quarter to $60.5M.

Based on CVI Holdings's 13F filing for Q3 2018, filed 14 Nov 2018.